Status:
COMPLETED
An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Atherosclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to validate novel assays for serum biomarkers of lipid metabolism (PCSK9 and LDL receptor) and to obtain information about how these biomarkers differ in subjects with nor...
Eligibility Criteria
Inclusion
- Hypercholesterolemia
- Statin monotherapy
Exclusion
- Significant acute or chronic illness
- Secondary causes of hypercholesterolemia
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00847782
Start Date
March 1 2009
End Date
September 1 2009
Last Update
November 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Montreal, Quebec, Canada, H2W1R7